Survival following non-small cell lung cancer among Asian/Pacific Islander, Latina, and non-hispanic white women who have never smoked

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 3, 2011, Pages 545-554

  Gomez, Scarlett Lin ^a,b   Chang, Ellen T ^a,b   Shema, Sarah J ^a   Fish, Kari ^a   Sison, Jennette D ^c   Reynolds, Peggy ^a,b   Clément Duchêne, Christelle ^d   Wrensch, Margaret R ^c   Wiencke, John L ^c   Wakelee, Heather A ^b  

^a CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; CULTURAL ANTHROPOLOGY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PACIFIC ISLANDER; PRIORITY JOURNAL;

AGED; CALIFORNIA; CARCINOMA, NON-SMALL-CELL LUNG; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; OCEANIC ANCESTRY GROUP; SMOKING; SURVIVAL RATE;

EID: 79955750912     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0965     Document Type: Article

References (53)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al. SEER Cancer Statistics Review, 1975-2006, based on November 2008 SEER data submission, posted to the SEER web site. Available from:http://seer.cancer.gov/ csr/1975-2006/. Bethesda, MD: National Cancer Institute; 2009.
3. Centers for Disease Control and Prevention (CDC). Prevalence of cigarette use among 14 racial/ethnic populations - United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2004;53:49-52.
4. Rudin CM, Avila-Tang E, Samet JM. Lung cancer in never smokers: a call to action. Clin Cancer Res 2009;15:5622-5.
5. Samet JM, Avila-Tang E, Boffetta P, Hannan LM, Olivo-Marston S, Thun MJ, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res 2009;15:5626-45.
6. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25:561-70. (Pubitemid 350002964)
7. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, et al. Lung cancer incidence in never smokers. J Clin Oncol 2007;25:472-8. (Pubitemid 350002951)
8. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers - a different disease. Nat Rev Cancer 2007;7:778-90. (Pubitemid 47463669)
9. Ou SH, Ziogas A, Zell JA. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol 2009;4:1083-93.
10. Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry CP Jr, et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer 2008;123:2095-104.
11. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001;12:703-11. (Pubitemid 32803497)
12. The Annual Utilization Report of Hospitals. Sacramento, CA: Office of Statewide Health Planning and Development; 2001.
13. California Health Interview Survey. California Health Interview Survey (CHIS) 2005 [cited 2007 Mar 6]. Available from:www.chis.ucla.edu.
14. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006;354:333-42. (Pubitemid 43145058)
15. Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health 2004;95:14-21.
16. Singh GK, Siahpush M. Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of two national data bases. Hum Biol 2002;74:83-109. (Pubitemid 34220324)
17. Markides KS, Coreil J. The health of Hispanics in the southwestern United States: an epidemiologic paradox. Public Health Rep 1986;101:253-65. (Pubitemid 16056293)
18. Scribner R. Paradox as paradigm - the health outcomes of Mexican Americans. Am J Public Health 1996;86:303-5.
19. Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic paradox. Ethn Dis 2001;11:496-518. (Pubitemid 33584373)
20. Borrayo EA, Guarnaccia CA. Differences in Mexican-born and U.S.-born women of Mexican descent regarding factors related to breast cancer screening behavior. Health Care Women Int 2000;21:599-613. (Pubitemid 33691083)
21. Turra CM, Elo IT. The impact of Salmon bias on the Hispanic mortality advantage: new evidence from Social Security data. Popul Res Policy Rev 2008;27:515-30.
22. Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 2007;110:1532-41.
23. Zell JA, Ou SH, Ziogas A, Anton-Culver H. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules. Cancer 2008;112:136-43.
24. Takaki R. Strangers from a Different Shore: a History of Asian Americans. New York, NY: Penguin Books; 1989.
25. Ou SH, Ziogas A, Zell JA. A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status. J Thorac Oncol 2010;5:158-68.
26. Studts JL, Ghate SR, Gill JL, Studts CR, Barnes CN, LaJoie AS, et al. Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiol Biomarkers Prev 2006;15:1825-8. (Pubitemid 44664255)
27. Pierce JP, Dwyer T, DiGiusto E, Carpenter T, Hannam C, Amin A, et al. Cotinine validation of self-reported smoking in commercially run community surveys. J Chronic Dis 1987;40:689-95. (Pubitemid 17113475)
28. Haddow JE, Palomaki GE, Knight GJ. Use of serum cotinine to assess the accuracy of self reported non-smoking. BMJ (Clin Res Ed) 1986;293:1306.
29. Perez-Stable EJ, Marin BV, Marin G, Brody DJ, Benowitz NL. Apparent underreporting of cigarette consumption among Mexican American smokers. Am J Public Health 1990;80:1057-61. (Pubitemid 20261379)
30. Lee PN. Lung cancer and passive smoking: association of an artefact due to misclassification of smoking habits?Toxicol Lett 1987;35:157-62.
31. Wagenknecht LE, Burke GL, Perkins LL, Haley NJ, Friedman GD. Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am J Public Health 1992;82:33-6.
32. Schofield PE, Hill DJ. How accurate is in-patient smoking status data collected by hospital admissions staff?Aust N Z J Public Health 1999;23:654-6.
33. McCullough A, Fisher M, Goldstein AO, Kramer KD, Ripley-Moffitt C. Smoking as a vital sign: prompts to ask and assess increase cessation counseling. J Am Board Fam Med 2009;22:625-32.
34. Ou SH, Zell JA, Ziogas A, Anton-Culver H. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer 2008;112:2011-20. (Pubitemid 351574077)
35. Gomez SL, O'Malley CD, Stroup A, Shema SJ, Satariano WA. Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer 2007;7:193.
36. Lai H, Lai S, Krongrad A, Trapido E, Page JB, McCoy CB. The effect of marital status on survival in late-stage cancer patients: an analysis based on surveillance, epidemiology, and end results (SEER) data, in the United States. Int J Behav Med 1999;6:150-76. (Pubitemid 29379109)
37. Subramanian J, Velcheti V, Gao F, Govindan R. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC). J Thorac Oncol 2007;2:827-30. (Pubitemid 47361024)
38. Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 2006;106:2428-36. (Pubitemid 43787667)
39. Herbst RS, Prager D, Hermann R, Fehrenbacher L, Johnson BE, Sandler A, et al. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 2005;23:5892-9.
40. Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med 2005;353:133-44. (Pubitemid 41058345)
41. Thatcher N, Chang A, Parikh P, Rodrigues Pereira J, Ciuleanu T, von Pawel J, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 2005;366:1527-37. (Pubitemid 41540110)
42. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-32. (Pubitemid 41058344)
43. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, Nishiwaki Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009 Sep 3;361(10):947-57.
44. Lee JS, Park K, Kim SW, Lee DH, Kim HT, Han JY, et al. A randomized phase III study of gefitinib versus standard chemotherapy (gemcitabine plus cisplatin) as a first-line treatment for never-smokerswith advanced or metastatic adenocarcinoma of the lung. In: International Association for the Study of Lung Cancer 13th World Conference on Lung Cancer Proceedings. San Francisco, CA; July 31-Aug 4, 2009 Journal of Thoraicc Oncology Vol 4(9) (suppl) Sept 2009 abstr PRS.4, S283.
45. Chang ET, Shema SJ, Wakelee HA, Clarke CA, Gomez SL. Uncovering disparities in survival after non-small-cell lung cancer among Asian/Pacific Islander ethnic populations in California. Cancer Epidemiol Biomarkers Prev 2009;18:2248-55.
46. Florescu M, Hasan B, Seymour L, Ding K, Shepherd FA. A clinical prognostic index for patients treated with erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Thorac Oncol 2008;3:590-8. (Pubitemid 351787301)
47. Wells AJ, English PB, Posner SF, Wagenknecht LE, Perez-Stable EJ. Misclassification rates for current smokers misclassified as nonsmokers. Am J Public Health 1998;88:1503-9. (Pubitemid 28455758)
48. Gilpin EA, Pierce JP, Cavin SW, Berry CC, Evans NJ, Johnson M, et al. Estimates of population smoking prevalence: self- vs proxy reports of smoking status. Am J Public Health 1994;84:1576-9. (Pubitemid 24323412)
49. Navarro AM. Smoking status by proxy and self report: rate of agreement in different ethnic groups. Tob Control 1999;8:182-5.
50. Hyland A, Cummings KM, Lynn WR, Corle D, Giffen CA. Effect of proxy-reported smoking status on population estimates of smoking prevalence. Am J Epidemiol 1997;145:746-51. (Pubitemid 27175286)
51. Giordano SH, Kuo YF, Duan Z, Hortobagyi GN, Freeman J, Goodwin JS. Limits of observational data in determining outcomes from cancer therapy. Cancer 2008;112:2456-66.
52. Markides KS, Eschbach K. Aging, migration, and mortality: current status of research on the Hispanic paradox. J Gerontol B Psychol Sci Soc Sci 2005;60:68-75. (Pubitemid 41552230)
53. Patel KV, Eschbach K, Ray LA, Markides KS. Evaluation of mortality data for older Mexican Americans: implications for the Hispanic paradox. Am J Epidemiol 2004;159:707-15. (Pubitemid 38405385)